文献速递关节外科

围手术期全身性地塞米松减少全关节置换术住院时间:随机对照试验的系统综述与Meta分析

Perioperative Systemic Dexamethasone Reduces Length of Stay in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · J Arthroplasty · 2020-10-16

结果显示,激素可缩短住院时间(MD=-0.39天,95%CI -0.61至-0.18),降低术后疼痛和PONV,不增加感染、静脉血栓栓塞或消化道出血风险,但升高血糖。

要点

  • 围手术期全身性激素缩短住院时间,24小时追加剂量进一步缩短。
  • 激素降低术后第0、1、2天疼痛和PONV,高剂量(15-20 mg地塞米松)对活动痛和PONV效果更佳。
  • 激素不增加感染、静脉血栓栓塞或消化道出血,但升高血糖(MD=5.30 mg/dL)。

核心结论

  • 围手术期全身性糖皮质激素安全,可促进单侧全膝关节和全髋关节置换术后早期出院并改善恢复。
  • 较高剂量(15-20 mg地塞米松)与活动痛和PONV进一步降低相关,重复给药可能进一步缩短住院时间。

研究设计与样本

  • 系统综述与随机对照试验的Meta分析,检索MEDLINE、EMBASE和Cochrane Library从建库至2020年6月1日。

主要发现

  • 围手术期糖皮质激素缩短住院时间(MD=-0.39天,95%CI -0.61至-0.18)。
  • 24小时追加糖皮质激素进一步缩短住院时间(MD=-0.33,95%CI -0.55至-0.11)。
  • 糖皮质激素降低术后第0天疼痛(MD=-1.99,95%CI -3.30至-0.69)和第1天疼痛(MD=-1.47,95%CI -2.15至-0.79),并降低第2天疼痛。

关键数值与推荐

  • 糖皮质激素不增加感染(P=1.000)、静脉血栓栓塞(P=1.000)或消化道出血(P=1.000)发生率。
  • 糖皮质激素与血糖升高相关(MD=5.30 mg/dL,95%CI 2.69-7.90)。

临床怎么用

  • 围手术期可考虑使用全身性地塞米松以缩短住院时间、减轻疼痛和PONV,高剂量(15-20 mg)可能更有效,重复给药或进一步获益。
  • 使用时需监测血糖,尤其对糖尿病患者,但感染、静脉血栓栓塞和消化道出血风险未见增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this review is to examine the effect of perioperative systemic corticosteroids at varying doses and timings on early postoperative recovery outcomes following unilateral total knee and total hip arthroplasty. The primary outcome was length of stay (LOS). METHODS: A systematic review and meta-analysis of randomized controlled trials was performed. MEDLINE, EMBASE, and Cochrane Library databases were searched from inception to June 1, 2020. Studies comparing the outcome of adult patients receiving a systemic steroid to patients who did not receive steroids were included. RESULTS: Seventeen studies were included, incorporating 1957 patients. Perioperative corticosteroids reduced hospital LOS (mean difference [MD] = -0.39 days, 95% confidence interval [CI] -0.61 to -0.18). A subsequent dose of corticosteroid at 24 hours further reduced LOS (MD = -0.33, 95% CI -0.55 to -0.11). Corticosteroids resulted in reduced levels of pain on postoperative day (POD) 0 (MD = -1.99, 95% CI -3.30 to -0.69), POD1 (MD = -1.47, 95% CI -2.15 to -0.79), and POD2. Higher doses were more effective in reducing pain with activity on POD0 (P = .006) and 1 (P = .023). Steroids reduced the incidence of PONV on POD1 (log odds ratio [OR] = -1.05, 95% CI -1.26 to -0.84) and POD2, with greater effect at higher doses (P = .046). Corticosteroids did not increase the incidence of infection (P = 1.000), venous thromboembolism (P = 1.000), or gastrointestinal hemorrhage (P = 1.000) but were associated with an increase in blood glucose (MD = 5.30 mg/dL, 95% CI 2.69-7.90). CONCLUSION: Perioperative corticosteroids are safe, facilitate earlier discharge, and improve patient recovery following unilateral total knee arthroplasty and total hip arthroplasty. Higher doses (15-20 mg of dexamethasone) are associated with further reductions in dynamic pain and PONV, and repeat dosing may further reduce LOS.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lex JR, Edwards TC, Packer TW, et al. Perioperative Systemic Dexamethasone Reduces Length of Stay in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Arthroplasty. 2020. PMID: 33190999. doi:10.1016/j.arth.2020.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。